WEST CHESTER, PA — VESTECK, Inc., a leading endovascular aortic disease repair (EVAR/TEVAR) company, is celebrating the continued success of its ‘SUTURE-TIGHT’ catheter following the completion of two additional clinical cases. With these latest procedures, the VESTECK ‘SUTURE-TIGHT’ device has now been used to secure EVAR grafts from various commercial vendors in a total of nine patients.
The procedures were conducted by Professor Dainis Krievins and a team of vascular surgeons and interventional radiologists. The team successfully implanted ‘SUTURE-TIGHT’ nitinol sutures in two patients undergoing abdominal aortic aneurysm repair procedures (EVAR).
Professor Krievins, who also serves as the Director of the Institute of Research at Pauls Stradins Clinical University Hospital and Professor at the University of Riga, Latvia, noted that the current ‘SUTURE-TIGHT’ device’s enhanced flexibility and ease of use allowed for precise suture placement and reduced procedure time.
“These are very exciting times at VESTECK,” commented Joe Rafferty, CEO of VESTECK. “Nine clinical cases have been successfully completed by five different Interventionalists, which sends a great message. The ‘SUTURE-TIGHT’ device has enabled multiple clinicians to place sutures, securing EVAR grafts with the goal of helping someone’s mom or dad, brother or sister.”
VESTECK’s ‘SUTURE-TIGHT’ catheter has been making waves in the medical community for its successful role in EVAR procedures, which aim to repair aortic diseases—a significant global unmet need. The recent success of the device in these additional clinical cases marks an important step forward in the company’s mission.
Professor Krievins recently presented this early experience with the ‘SUTURE-TIGHT’ catheter at the VEITH Symposium in New York City, further solidifying the device’s growing reputation within the medical community.